Correlations between Diffusion Tensor Imaging (DTI) and Magnetic Resonance Spectroscopy (1H MRS) in schizophrenic patients and normal controls by Tang, Cheuk Y et al.
BioMed  Central
Page 1 of 11
(page number not for citation purposes)
BMC Psychiatry
Open Access Research article
Correlations between Diffusion Tensor Imaging (DTI) and Magnetic 
Resonance Spectroscopy (1H MRS) in schizophrenic patients and 
normal controls
Cheuk Y Tang*1,2,4, Joseph Friedman2, Dikoma Shungu5, Linda Chang6, 
Thomas Ernst6, Daniel Stewart2, Arash Hajianpour1, David Carpenter1, 
Johnny Ng1, Xiangling Mao5, Patrick R Hof3, Monte S Buchsbaum2, 
Kenneth Davis2 and Jack M Gorman2
Address: 1Department of Radiology, Mount Sinai School of Medicine NY, NY 10029, USA, 2Department of Psychiatry, Mount Sinai School of 
Medicine NY, NY 10029, USA, 3Department of Neuroscience, Mount Sinai School of Medicine NY, NY 10029, USA, 4Department of Pathology, 
Mount Sinai School of Medicine NY, NY 10029, USA, 5Department of Radiology, Weill Medical College of Cornell University, NY, NY 10021, USA 
and 6Department of Medicine, University of Hawaii, HI 96817, USA
Email: Cheuk Y Tang* - Cheuk.tang@mssm.edu; Joseph Friedman - jfriedman1@rcn.com; Dikoma Shungu - dcs4070@msn.com; 
Linda Chang - lchang@hawaii.edu; Thomas Ernst - tmernst@hawaii.edu; Daniel Stewart - Daniel.Stewart@mssm.edu; 
Arash Hajianpour - hajianpour@hotmail.com; David Carpenter - David.carpenter@mssm.edu; Johnny Ng - johnnycng@hotmail.com; 
Xiangling Mao - xim2004@med.cornell.edu; Patrick R Hof - Patrick.Hof@mssm.edu; Monte S Buchsbaum - Monte.Buchsbaum@mssm.edu; 
Kenneth Davis - Kenneth.Davis@mssm.edu; Jack M Gorman - jackgorm@gmail.com
* Corresponding author    
Abstract
Background:  Evidence suggests that white matter integrity may play an underlying
pathophysiological role in schizophrenia. N-acetylaspartate (NAA), as measured by Magnetic
Resonance Spectroscopy (MRS), is a neuronal marker and is decreased in white matter lesions and
regions of axonal loss. It has also been found to be reduced in the prefrontal and temporal regions
in patients with schizophrenia. Diffusion Tensor Imaging (DTI) allows one to measure the
orientations of axonal tracts as well as the coherence of axonal bundles. DTI is thus sensitive to
demyelination and other structural abnormalities. DTI has also shown abnormalities in these
regions.
Methods: MRS and DTI were obtained on 42 healthy subjects and 40 subjects with schizophrenia.
The data was analyzed using regions of interests in the Dorso-Lateral Prefrontal white matter,
Medial Temporal white matter and Occipital white matter using both imaging modalities.
Results: NAA was significantly reduced in the patient population in the Medial Temporal regions.
DTI anisotropy indices were also reduced in the same Medial Temporal regions. NAA and DTI-
anisotropy indices were also correlated in the left medial temporal region.
Conclusion: Our results implicate defects in the medial temporal white matter in patients with
schizophrenia. Moreover, MRS and DTI are complementary modalities for the study of white
matter disruptions in patients with schizophrenia.
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Background
Alterations in connectivity between brain regions includ-
ing the frontal lobe, basal forebrain and limbic system,
have been proposed as network deficits in schizophrenia
[1-6]. Connections between the prefrontal cortex (PFC)
and other cortical and subcortical regions implicated in
the pathophysiology of schizophrenia suggest that a white
matter abnormality in this region could have widespread
consequences for neural connectivity in brain regions that
are critical to the core symptoms of schizophrenia. The
finding of increased neuronal density [7-13] is consistent
with the notion that the integrity of white matter tracts is
compromised. In addition, MRI evidence for decreased
global [14-16], prefrontal [15,17-21] and temporal
[15,21] white matter in schizophrenia is quite convincing.
A meta-analysis of studies of white matter volumes in
schizophrenia reveals a reduction of approximately 2%,
with the greatest differences of approximately 5% in
medial temporal lobe structures [14]. Indeed, regional
rather than global reductions are far more relevant to the
question of the origins of disconnectivity and hence of
particular interest in the presentation of symptoms. For
example, volume reductions in the white matter of PFC,
repeatedly found in schizophrenia [17-20], are associated
with the presentation of negative symptoms [18,20].
Both MRS [22,39,41,42,44,46,23-27] and DTI [28-34]
have been used extensively to study white matter abnor-
malities in patients with schizophrenia. The results of
these two techniques may reflect different mechanisms of
abnormal pathologies. MRS measurements are deter-
mined by biochemical profiles of the underlying patholo-
gies, whereas DTI is more sensitive to structural
differences.
Magnetic resonance spectroscopy allows one to quantify
the concentrations of various metabolites in the brain. N-
acetylaspartate (NAA) is the most prominent metabolite
detected in the normal human brain. NAA serves as a neu-
ronal marker and is only present in mature neurons. Some
studies have also shown the presence of NAA in oli-
godendrocyte-2A progenitor cells [35]. NAA has been
shown to be decreased in well-known demyelinating dis-
eases such as multiple sclerosis (MS) and progressive
multifocal leukoencephalopathy (PML) and it is thought
to be associated with axonal injury [36]. Decreased NAA
in patients with schizophrenia has been found in the cer-
ebellum [37], thalamus [23,38-44], dorso-lateral prefron-
tal cortex (DLPFC) [23,42-44], anterior cingulate [45],
and medial temporal lobe [24-27,46,47]. Reduction in
NAA may signify structural abnormality or reduced viabil-
ity of the underlying neurons [35,48]. Given these results
we have acquired MRS data on the DLPFC white matter,
medial temporal (MT) white matter and on the occipital
(OC) white matter as a reference.
Diffusion tensor imaging allows one to quantify the integ-
rity of densely packed fiber bundles such as axonal tracts
and to measure the orientation of such bundles [49-53].
DTI probes the microstructure of white matter by measur-
ing the anisotropy of self-diffusion of water molecules in
the restricted compartments of axonal tracts. Two quanti-
tative measures can be obtained from DTI: anisotropy
indices and fiber tract orientations. Anisotropy indices
such as relative anisotropy (RA) and fractional anisotropy
(FA) [49,53] measure the amount of coherence of water
diffusion which putatively reflects the amount of myelina-
tion in axonal bundles or the coherence of fiber tracts. The
same dataset also provides information on the three-
dimensional orientation of the anisotropy and can be
used to study fiber tract connectivity [54-56]. Previous
DTI studies have shown reduced anisotropy in patients
with schizophrenia in frontal white matter [28,29,57,58],
the cingulum bundle [31,59], the temporal gyrus [32,60],
and the corpus callosum [32,34,61].
Given that MRS and DTI can provide complementary
imaging data on white matter changes in brain we sought
to investigate the white matter brain changes associated
with schizophrenia by simultaneously acquiring DTI and
MRS data in a cohort of schizophrenic patients and a
group of matched healthy control subjects. MRS was
acquired targeting three regions of interests: frontal white
matter, occipital white matter and medial temporal white
matter. Since the DTI scans are much less time-consuming
than MRS scans, we acquired whole brain DTI and
extracted matching voxels for correlation analysis with the
MRS voxels.
Methods
Subjects
Schizophrenic subjects were recruited from inpatient, out-
patient, day treatment and vocational rehabilitation serv-
ices at Mount Sinai Hospital (New York, N.Y.), Pilgrim
Psychiatric Center (W. Brentwood, N.Y.), Bronx VA Medi-
cal Center (Bronx, N.Y.), Hudson Valley Veterans Affairs
Medical Center (Montrose, N.Y.), and Queens Hospital
Center (Jamaica, N.Y.) following approvals by each insti-
tutional review board. Informed consent was obtained on
each subject following an assessment of capacity to pro-
vide informed consent by a psychiatrist independent of
the study. The inclusion criteria were 1) a DSMIV diagno-
sis of schizophrenia or schizoaffective disorder based on
the Comprehensive Assessment of Symptoms And His-
tory (CASH) [62], and 2) aged 18–80. Healthy compari-
son subjects who were without any DSMIV axis I disorder
(by CASH interview) were recruited from the New York
area and were matched for age and gender to the schizo-
phrenic subjects, they also provided informed consent.
Subjects were excluded if they had 1) a positive urine
drugs of abuse screen, 2) a medical diagnosis which mayBMC Psychiatry 2007, 7:25 http://www.biomedcentral.com/1471-244X/7/25
Page 3 of 11
(page number not for citation purposes)
produce white matter changes (i.e. HIV, MS), 3) a history
of brain disorder which may produce cognitive impair-
ment or behavioral symptoms (i.e. head injury, cerebrov-
ascular disease), or 4) had an unstable medical condition
(i.e. poorly controlled diabetes or hypertension, sympto-
matic coronary artery disease). Each subject was carefully
screened and evaluated with a neuropsychological evalu-
ation, structured assessment of symptoms, screening med-
ical history, physical examination and laboratory studies
(including complete blood count, routine chemistry, liver
enzymes, and thyroid function tests) and urine toxicology
screen, to ensure they fulfilled the inclusion criteria.
42 schizophrenic subjects and 40 healthy comparison
subjects were recruited, assessed and scanned with both
DTI and MRS modalities. Mean age of the schizophrenic
group did not differ significantly from the healthy com-
parison group (schizophrenic mean = 38.69 years [sd =
11.42]), healthy comparison mean = 43.3 years [sd =
20.18], t = 1.28, p = .20), nor did the gender distribution
(healthy comparison males = 57.5%, schizophrenic males
= 69%, X2 = 1.18, p = .28). However, schizophrenic sub-
jects attained significantly lower levels of education than
the healthy comparison subjects (schizophrenic mean =
12.21 years [sd = 2.07]), healthy comparison mean = 15.3
years [sd = 2.24], t = 6.48, p < .001). The average age of ill-
ness onset for the schizophrenic group was 23.53 years
(sd = 7.09), 5% of the schizophrenic sample was not
receiving treatment with any antipsychotic at the time of
scanning while 19% were receiving first generation antip-
sychotics, 17% clozapine, and 59% were receiving other
second generation antipsychotics (risperidone, olanzap-
ine, ziprasidone, quetiapine, aipiprazole).
Data Acquisition
All imaging studies were performed on an Allegra 3T
head-dedicated system (Siemens, Ehrlangen, Germany)
with a gradient strength of 40 mT/m and slew rate of
400~900 mT/m/s, allowing EPI acquisitions with mini-
mal susceptibility distortions. Patient head motion was
minimized by inflatable pillows inserted between the
patients' head and the head coil. Subjects were recruited to
receive two scans, one MRS and one structural. Most sub-
jects received both scans on the same day, but there were
some that preferred to return on a second day for the other
scan. The duration between the two scans was at most 2
months apart. During this time there was no change in
treatment that the patients received.
MRS
Localizer MR images for prescribing the MRS volumes
consisted of a T1 sagittal with the following parameters:
TR = 500 ms, TE = 10 ms, FOV = 18 cm × 14 cm, matrix
size = 512 × 384, 4.3 mm thick with 1.1 mm spacing. 25
slices were obtained to cover the whole brain. From these
sagittal images, two T1-weighted transverse slices (TR =
500 ms, TE = 10 ms, Thickness = 10 mm, FOV = 16.5 cm
× 22 cm with matrix 512 × 384) were identified for MRS
acquisition: the first slice covered the DLPFC white matter
and the OC white matter. A nearly axial plane was chosen
for the plane going through the striatum. It is chosen to be
parallel to the AC-PC line as identified on the sagittal
planes (Fig 1). The second slice was prescribed to be co-
axial with the Sylvian fissure such that it contained the
medial temporal lobe white matter bilaterally (Fig 2). 1H
spectroscopic imaging (SI) data of the left and right
medial temporal lobes were obtained in two sequential
scans using the phase-encoded version of the standard
PRESS volume localization sequence, with TR = 2000 ms,
TE = 30 ms, 24 × 24 phase-encoding steps over a field-of-
view of 16 cm (zerofilled to 32 × 32 phase-encoding steps
before 3D Fourier transformation), a slice thickness of 10
cm slice, 1 average per phase-encoding step and circular k-
space sampling, to obtain voxels having a nominal size of
0.25 cm3 (1.0 × 0.5 × 0.5 cm3). Outer volume saturation
bands were prescribed to coincide with all 8 sides of the
PRESS box. Water suppression and magnet shimming
were automatically performed and adjusted by the host
computer. The 1H SI data for the DLPFC were acquired
with the same protocol except that the FOV changed to 30
cm. The resulting interpolated pixel size was (1.0 × 0.9 ×
09 cm3). One slice was acquired for the DLPFC and OC
white matter tracts. Total imaging time for all three slices
averaged about 75 minutes.
T1-weighted axial slice for DLPF wm and OCC wm regions  with CSI acquisition matrix and ROIs for metabolites quanti- fication superimposed Figure 1
T1-weighted axial slice for DLPF wm and OCC wm regions 
with CSI acquisition matrix and ROIs for metabolites quanti-
fication superimposed.BMC Psychiatry 2007, 7:25 http://www.biomedcentral.com/1471-244X/7/25
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The raw SI data were processed and fitted in the fre-
quency-domain to obtain metabolite peak areas using
manufacturer-supplied MRS data processing software.
Individual CSI images were reconstructed and overlaid
onto the T1 anatomical images. Automatic phase correc-
tion was applied, voxels of interests were identified, and
the metabolite levels were derived from the spectral fits.
For the DLPFC white matter and OC white matter ROIs,
three voxels were identified visually (Fig 1) for each hem-
isphere. For the MT white matter four voxels were identi-
fied per hemisphere because of the higher CSI resolution
(Fig 2). MRS metabolites (NAA, Cho, Cr, Ins1 & Ins2)
were obtained from these regions of interests (ROIs) (Fig
3). The number of voxels per ROI was variable ranging
between 1 and 3. Voxels with poor spectral data quality,
defined asunresolved Cr and Cho resonances, were
excluded from analysis. The metabolites from the selected
voxels in each of the ROIs were averaged and transferred
to Statistica v6 (StatSoft Inc., Tulsa, Ok) for statistical
analysis.
DTI
DTI data was acquired in a separate scanning session that
included other structural scans for morphological analy-
sis. The protocol for the structural scans consisted of a
three-plane sagittal localizer from which all other struc-
tural scans were prescribed. The following structural scans
were acquired: Axial 3D-MPRage (TR = 2500 ms, TE = 4.4
ms, FOV = 21 cm, matrix size = 256 × 256, 208 slices with
thickness = 0.82 mm); Turbo spin echo T2-weighted Axial
(TR = 5380 ms, TE = 99 ms, FOV = 18.3 cm × 21 cm,
matrix = 512 × 448, Turbo factor = 11, 28 slices, thickness
= 3 mm skip 1 mm); DTI using a pulsed-gradient spin-
echo sequence with EPI-acquisition (TR = 4100 ms, TE =
80 ms, FOV = 21 cm, matrix = 128 × 128, 28 slices, thick-
ness = 3 mm skip 1 mm, b-factor = 1250 s/mm2, 12 gradi-
ent directions, 5 averages); and magnetization transfer
imaging (MTI) using a turbo spin echo sequence (TR =
700 ms, TE = 12 ms, FOV = 21 cm, Matrix = 256 × 256, 28
slices, thickness = 3 mm skip 1 mm). Total imaging time
for the structural scans averaged about 50 minutes.
Raw DTI data were transferred to an off-line workstation
for post-processing. In-house software written in Matlab
v6.5 (The Mathworks Inc. Natick, MA) was used to com-
pute the anisotropy and vector maps. The Fractional Ani-
sotropy images were then converted to analyze format
(Fig 4). MEDx  v3.4.3 software (Medical Numerics Inc,
Sterling, VA) was used to inspect and define ROIs on the
FA images. Two adjacent axial slices (4 mm) were selected
from the FA dataset for each matching CSI image (10
mm). The planes were selected to contain the same CSI
voxel locations (Fig 5). The voxels for the FA images meas-
ured 1.6 × 1.6 × 3 mm3. ROI dimensions for the FA images
were set to 5 × 5 and 3 × 3 for the DLPFC/OC and MT
respectively. These settings gave us the closest match to the
T1-weighted axial slices for left and right MT wm regions with CSI acquisition matrix superimposed as well as ROIs for metab- olites quantification Figure 2
T1-weighted axial slices for left and right MT wm regions with CSI acquisition matrix superimposed as well as ROIs for metab-
olites quantification.BMC Psychiatry 2007, 7:25 http://www.biomedcentral.com/1471-244X/7/25
Page 5 of 11
(page number not for citation purposes)
MRSI data in terms of actual volumes sampled; ROI
dimensions for DLPFC and OC were 8.2 mm (FA) vs. 9
mm (MRSI), ROI dimensions for the MT were 4.9 mm
(FA) vs. 5 mm (MRSI). For all structures 2 FA slices were
sampled corresponding to a thickness of 8 mm (FA) vs. 10
mm (MRSI). The FA voxel statistics for each ROI were
extracted and transferred to Statistica  and merged with
MRS data for t-tests and correlation analysis.
In order to ensure reliability of our region of interest pro-
cedures inter-rater reliability measures were calculated for
the two raters for each white matter region in 20 subjects.
The intraclass correlation coefficients on the mean values
of the ROIs as obtained by the two raters were as follows;
optic radiations (right = .83, left = .83), MT (right = .88,
left = .91), DLPF WM (right = .94, left = .84).
Results
Statistical tests between the average ROI values were per-
formed on the fractional anisotropy as well as the MRSI
data for the three regions of interests in both hemispheres.
Table 1 shows the mean fractional anisotropy and metab-
olite ratio values for the schizophrenic and healthy com-
parison groups in each medial temporal regions of
interest. Independent T-tests on the metabolite ratios
demonstrated significantly reduced NAA in the left medial
temporal white matter regions in patients with schizo-
phrenic subjects (mean = 1.17) compared to healthy con-
trol subjects (mean = 1.31) (t = 2.35, df = 75, p < .021).
Similar significances were found in the right medial tem-
poral white matter regions with schizophrenic subjects
(mean = 1.07) and healthy control subjects (mean = 1.21)
(t = 2.29, df = 75, p < .025). We also computed the signif-
icances for NAA/Cr ratios in the medial temporal white
matter region. Significant differences were found in the
left with schizophrenic subjects (mean = 1.96) and
healthy controls (mean = 2.37) (t = 2.58, df = 75, p <
0.012) as well as on the right with schizophrenic subjects
(mean = 1.94) and healthy controls (mean = 2.25) (t =
2.17, df = 75, p < 0.033). Other areas and metabolite con-
centrations were not significantly different between
groups.
T-tests on the matching voxels of the FA data showed sig-
nificantly reduced FA values in the same right medial tem-
poral white matter voxels as the MRS in patients with
schizophrenia compared to normal control subjects
(0.307 vs. 0.342) (t = 3.02, df = 79, p < .003). FA was also
significantly reduced in the left medial temporal white
matter region of schizophrenic subjects compared to
healthy control subjects (0.339 vs. 0.370) (t = 2.31, df =
79, p < .023). Other areas surveyed were not significant.
Example of MRS spectrum of a MT wm voxel (blue square) extracted from a 2D-CSI acquisition Figure 3
Example of MRS spectrum of a MT wm voxel (blue square) extracted from a 2D-CSI acquisition. Visible metabolite peaks 
shown are NAA, Cr, Cho, Ins1 and Ins2.BMC Psychiatry 2007, 7:25 http://www.biomedcentral.com/1471-244X/7/25
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Correlation analysis on combined patient and control
subjects showed a significant correlation between FA and
NAA in the left medial temporal (r = 0.210, p = .050) as
well as FA and NAA/Cr (r = 0.230, p = 0.040). No signifi-
cant correlation was found in the right medial temporal
side (r = 0.210, p = 0.090) and (r = 0.140, p = 0.220).
There have been several reports suggesting that additional
neuro-degenerative factors such as age might have effects
on FA [63,64]. NAA in our patient sample as well as some
other studies [65] did not show any age effect. We have
also tested partial correlations with the FA values cor-
rected for age: a slight increase in significances were found
in the same regions, correlations between FA and NAA,
NAA/Cr in the left medial temporal white matter were (r
= 0.332., p = .010) and (r = 0.308, p = 0.017) respectively.
The correlations in all other ROIs surveyed were not sig-
nificant: right medial temporal side (r = 0.20, p = 0.07)
and (r = 0.16, p = 0.22); left DLPFC (r = 0.03, p = 0.80)
and (r = -0.07, p = 0.56), right DLPFC (r = 0.07, p = 0.56)
and (r = 0.23, p = 0.06), left occipital (r = 0.13, p = 0.10)
and (r = 0.15, p = 0.21), right occipital (r = 0.10, p = 0.39)
and (r = 0.18, p = 0.13) respectively.
Discussion
The regions sampled in the current study shows that NAA/
Cr and fractional anisotropy are reduced in the medial
temporal white matter in patients with schizophrenia.
Reduced anisotropy was detected in the areas surveyed
Diffusion Tensor Imaging: Whole-Brain Fractional Anisotropy Maps of normal control Figure 4
Diffusion Tensor Imaging: Whole-Brain Fractional Anisotropy Maps of normal control.BMC Psychiatry 2007, 7:25 http://www.biomedcentral.com/1471-244X/7/25
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despite normal appearing white matter on conventional
T1 and T2 weighted images which suggest microscopic
damage to these fiber tracts.
NAA is thought to be present almost exclusively in neu-
rons and their dendritic and axonal extensions but not in
glia [66-68]. The NAA signal provides a marker of the
number of viable neurons [69]. NAA is an intracellular
amino acid derivative produced in the mitochondria [70],
but it is also found in large quantities in O-2A progenitor
cells [35]. O2-A progenitor cells are putatively involved
with glia repair processes[71]. MS studies have shown that
it is the failure of these repair processes that is the main
cause of the disease [72]. A reduction in NAA may reflect
both a volume loss as well as a defect in the myelin main-
tenance infrastructure. FA indices from DTI measure-
ments reflect the amount of coherently restricted
diffusion (imposed by the presence of myelin) of free
Table 1: Mean values of metabolite ratios and fractional anisotropy (FA) and for the Medial Temporal, DLPFC and Occipital white 
matter ROIs. Significant differences between schizophrenic and healthy control subject groups by independent t tests are highlighted 
in bold.
NAA NAA/Cr FA
ROI Schizophrenic 
Mean (SD)
Control 
Mean (SD)
p Schizophrenic 
Mean (SD)
Control 
Mean (SD)
p Schizophrenic 
Mean (SD)
Control 
Mean (SD)
p
R Medial 
Temporal
1.076(0.233) 1.210(0.276) <0.025 1.937(0.556) 2.254(0.716) <0.033 0.307 (0.052) 0.342(0.073) <0.003
L Medial 
Temporal
1.171(0.273) 1.308(0.238) <0.021 1.956(0.732) 2.368(0.732) <0.012 0.370 (0.082) 0.339(0.064) <0.023
R Frontal 4.260(1.420) 3.970(1.230) p = 0.38 2.290(0.770) 1.990(0.610) p = 0.08 0.230 (0.043) 0.244 (0.055) p = 0.21
L Frontal 4.550(1.440) 4.450(1.330) p = 0.77 2.320(0.730) 2.280(1.080) p = 0.88 0.226(0.044) 0.237(0.052) p = 0.30
R Occipital 4.050(2.240) 4.070(1.320) p = 0.96 3.870(2.540) 2.360(0.780) p = 0.30 0.315(0.045) 0.325(0.051) p = 0.36
L Occipital 4.360(2.640) 4.270(1.520) p = 0.87 2.840(1.830) 2.520(0.730) p = 0.34 0.356(0.069) 0.364(0.059) p = 0.60
ROI locations (left) DLPF wm, OCC wm and (right) MT wm for Fractional Anisotropy Data Figure 5
ROI locations (left) DLPF wm, OCC wm and (right) MT wm for Fractional Anisotropy Data.BMC Psychiatry 2007, 7:25 http://www.biomedcentral.com/1471-244X/7/25
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water. These coherently restricted diffusion pathways are
most prominent in axonal bundles. DTI voxels are several
orders of magnitude larger than cellular dimensions, so
that the computed anisotropy indices reflect the cumula-
tive effect of the underlying microstructure. While there is
still controversy regarding the source of the anisotropy
such as the contribution of the intracellular versus extra-
cellular water to the diffusion signal [73-76], one can
argue from a physical point of view that a reduced anisot-
ropy can be the result of one of the following phenome-
non: loss of myelin leading to reduced restricted
diffusion, intact fibers but not coherently oriented and
loss of fibers. Measurements using multiple b-values have
shown a dependence of the diffusion signal on fast and
slow diffusion as well as a deviation from mono-exponen-
tial signal decay with higher b-values. With b-values
below 2000 s/mm2 the signal decays mono-exponentially
and is most sensitive to fast diffusion [74]. Our DTI data
was acquired with a b-value of 1250 s/mm2 and is thus
sensitized to fast diffusing water protons (probably in the
extra-cellular space).
In a systematic review of proton MRS investigations meas-
uring NAA differences between healthy controls and
patients with schizophrenia [77] levels of NAA do appear
to be substantially reduced in frontal WM and temporal
WM of schizophrenic patients. Although studies of tem-
poral WM NAA changes are less well corroborated than
frontal WM changes in schizophrenia the mean reduction
of FA in temporal WM across studies was estimated at
12.7% compared to 5.2% for frontal WM [77]. Moreover,
antipsychotic treatment of the patients in our study may
have confounded the measurements of NAA in the pre-
frontal white matter. In a longitudinal evaluation chronic
schizophrenic patients first scanned off medication then
after treatment was started NAA levels increased signifi-
cantly and selectively in the dorsolateral prefrontal cortex
within 4 weeks but not in temporal lobe or other areas
assessed [42]. The fact that we only found significant dif-
ferences in the medial temporal white matter may support
these findings.
Our group has previously published a report on the DTI
findings of the same subject population [78]. SPM analy-
sis showed that there were significant differences in the
medial temporal white matter as well as frontal white
matter regions. The areas of significance were in the same
locations as our ROI placements. The reason that we did
not find significant FA differences in the frontal white
matter is partly due to the size of the ROIs. The ROI
dimensions and locations chosen for the current analysis
was based on the need to match the voxels obtained from
the MRS data. These results suggest that axonal disrup-
tions in the frontal white matter areas might be limited to
specific tracts within the frontal white matter. The subjects
used for the current analysis is a subset of the subjects
used in our previous report (N = 55, S = 63) versus (N42,
S = 40) because some scans had to be eliminated due to
poorly resolved spectra.
A similar study was performed by Steel et. al. [79], but no
significant differences were found in NAA or FA. This
might have been due to several reasons. Single voxel MRS
is prone to partial volume contamination. Our technique
used multivoxel spectroscopic imaging with much smaller
voxel size; we only sampled the voxels which are well con-
tained within the white matter regions. The second reason
for the difference in findings may be due to our much
larger sample of subjects (n = 40/42 vs. n = 10/10) and
potential mean age differences (Steel's group = 35/34, this
study = 43/39). The Steel's group did not survey the
medial temporal lobe which was the location where we
found significances for both NAA and FA.
A more recent study has been performed by Irwan et. al.
[80] using DTI and CSI acquired in a supraventricular slice
in normal control subjects. Although they have not specif-
ically looked at isolated white matter voxels, they have
shown a significant positive correlation between NAA and
FA as well as a significant negative correlation between
NAA with ADC values which is consistent with our inter-
pretation of the FA index.
We also found significant correlations between FA and
NAA in the left medial temporal white matter. Despite the
co-occurrence of the reductions in NAA and fractional ani-
sotropy these values were not significantly correlated on
the right side (p = 0.07). These relatively weak significan-
ces were only observed when correlations were computed
with both control subjects and patients combined. There-
fore, these results between these two measures in the same
region may be suggestive of different structural and/or
metabolic changes co-occurring in the same region, but
independent of each other, in contrast to what is observed
in multiple sclerosis [81]. For example, patients with
schizophrenia may be born with proper axonal formation
but defective myelin maintenance infrastructure as
reflected by reduced NAA/Cr. This interpretation is rea-
sonable given that NAA is also found in large quantities in
O-2A progenitor cells [35] putatively involved with glia
repair processes [71]. In this scenario our results could be
interpreted such that the reduction of anisotropy in this
area might occur gradually whereas the low NAA/Cr levels
could be constant throughout the lifespan of the patients.
Low NAA may be a hallmark throughout the lifespan of
the disease but its effect and other factors on FA may be
more gradual.
One limitation of this study lies in the coregistration of
the MRS ROIs with the DTI ROIs. Due to the lower sensi-BMC Psychiatry 2007, 7:25 http://www.biomedcentral.com/1471-244X/7/25
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tivity of MRS, the acquisition of MRS data is inherently
slower and the resulting data is of lower resolution. We
were only able to acquire two slices of MRS data. This
made it impossible to accurately coregister the MRS slices
to the DTI slices using conventional computer algorithms.
The problem is compounded by the inherent distortions
that exists in EPI based DTI acquisition schemes. In this
study we have relied on our anatomy experts to visually
identify the regions of interests. To minimize the error we
have acquired the MRS slice for the DLPFC and the occip-
ital regions in the same plane as the DTI which was along
the AC-PC plane. This made it easier to identify the same
regions on both modalities. Other limitations are the dif-
ferences in slice thickness between the two modalities.
The MRS was 10 mm thick whereas the DTI were 3 mm
skip 1 mm. To minimize this difference we selected two
DTI slices for every MRS slice.
Conclusion
Our study has provided further evidence of white matter
abnormality in the medial temporal region in chronic
schizophrenic patients. This was evidenced through MR
Spectroscopy as well as Diffusion Tensor Imaging. Apply-
ing these two imaging modalities to an at risk population
at a younger age before the disease is diagnosed and cor-
relating the results with outcome would elucidate the
sequence of events such as defective NAA preceding
reduced FA. Differences in the MRS and DTI results may
help one distinguish the nature of the white matter
defects.
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